Fri Sep 20 13:07:00 UTC 2024: ## Koelis Partners with DeepHealth to Streamline Prostate Cancer Diagnosis and Treatment

**GRENOBLE, France and PRINCETON, N.J., Sept. 20, 2024 (GLOBE NEWSWIRE)** – Koelis, a leading innovator in prostate care, announced today a partnership with DeepHealth, a provider of AI-powered radiology informatics, to enhance prostate cancer diagnosis and treatment. This partnership integrates DeepHealth’s AI-powered software with Koelis’ Trinity 3D Ultrasound Platform, allowing for seamless fusion of MRI and ultrasound images for more accurate biopsies and targeted treatments.

The integration streamlines the prostate MRI reading process, enabling urologists and radiologists to collaborate efficiently. DeepHealth’s software provides automated prostate MRI segmentation, readily imported into Koelis Trinity for 3D patient-specific prostate mapping, guiding both diagnostic and treatment procedures.

“This partnership will facilitate the adoption of MRI fusion biopsy as a new standard of care in the USA,” said Antoine Leroy, Koelis founder and CEO. “We strongly believe that our collaboration with DeepHealth will improve the lives of our patients and enhance the capabilities of urologists.”

This collaboration is already yielding positive results. Dr. John Melnick, Medical Director at Lenox Hill Radiology, NYC, commented on the efficiency gains: “Since Koelis became compatible with DeepHealth Prostate, my job has been tremendously more efficient, not only from the perfect PACS integration, but also from the immediate AI-powered contouring feature it offers.”

Dr. Mitchell Fraiman, Director of Urology at Good Samaritan Hospital, echoed the benefits for urologists: “As the lead urologist performing the Koelis fusion biopsy, I need timely and accurate MRI contours. The efficiency gained eventually benefits our patients.”

Koelis’ Trinity system utilizes 3D ultrasound imaging with proprietary MRI-US fusion image guidance and prostate motion tracking software. This partnership with DeepHealth will further enhance its capabilities, offering more accurate biopsies and providing urologists with greater options for less invasive treatments.

This innovative collaboration is poised to revolutionize prostate cancer care by streamlining the diagnosis and treatment process, ultimately benefiting both patients and healthcare providers.

Read More